Vimta Labs Limited Stock NSE India S.E.

Equities

VIMTALABS

INE579C01029

Biotechnology & Medical Research

Market Closed - NSE India S.E. 07:43:50 2024-04-19 am EDT 5-day change 1st Jan Change
449.8 INR -1.32% Intraday chart for Vimta Labs Limited -5.89% +11.46%
Sales 2022 2.79B 33.43M Sales 2023 3.19B 38.27M Capitalization 6.95B 83.41M
Net income 2022 413M 4.95M Net income 2023 482M 5.78M EV / Sales 2022 2.53 x
Net Debt 2022 85.41M 1.02M Net cash position 2023 242M 2.9M EV / Sales 2023 2.1 x
P/E ratio 2022
17.2 x
P/E ratio 2023
14.7 x
Employees 1,368
Yield 2022
0.63%
Yield 2023
0.64%
Free-Float 32.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.32%
1 week-5.89%
Current month+1.34%
1 month-0.72%
3 months+3.40%
6 months-23.29%
Current year+11.46%
More quotes
1 week
442.20
Extreme 442.2
477.95
1 month
438.20
Extreme 438.2
496.95
Current year
404.00
Extreme 404
537.00
1 year
364.85
Extreme 364.85
623.15
3 years
177.00
Extreme 177
623.15
5 years
51.50
Extreme 51.5
623.15
10 years
51.50
Extreme 51.5
623.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 94-12-31
Founder 75 83-12-31
Director of Finance/CFO - 21-02-21
Members of the board TitleAgeSince
Founder 75 83-12-31
Chief Operating Officer 72 83-12-31
Chief Executive Officer 49 94-12-31
More insiders
Date Price Change Volume
24-04-19 449.8 -1.32% 24 845
24-04-18 455.8 -0.96% 9,547
24-04-16 460.2 +0.17% 15,313
24-04-15 459.4 -3.88% 19,092
24-04-12 478 -1.83% 14,440

Delayed Quote NSE India S.E., April 19, 2024 at 07:43 am EDT

More quotes
Vimta Labs Limited is engaged in the business of contract research and testing organization. The Company is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include Drug discovery, development, and drug life cycle management support services; Preclinical research and testing services for medical device companies; Contract research and testing for agrochemical and specialty chemical companies; and Food testing and analytical development services to support manufacturers, processors, farmers, and retailers; Clinical diagnostics services to patients, clinicians, and hospitals, and environmental regulatory services such as impact assessments and post project monitoring, to various industries, such as power and infrastructure.
More about the company